Skip to main content

Table 1 Baseline characteristics of 692 HIV-positive illicit drug users stratified by adherence to ART in the previous six months

From: Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis

Characteristic

<95% adherence

≥95% adherence

OR1

95% CI2

pvalue

301 (43.5) n (%)

392 (56.6) n (%)

Age

     

Median (IQR)

40 (34 – 45)

43 (36 – 48)

1.05

1.02 – 1.06

<0.001

Gender

     

Male

195 (64.8)

284 (72.6)

1.00

  

Female

106 (35.2)

107 (27.5)

0.69

0.50 – 0.96

0.027

Caucasian ancestry

     

No

143 (47.5)

140 (35.8)

1.00

  

Yes

158 (52.5)

251 (64.2)

1.62

1.19 – 2.20

0.002

Heroin injection3

     

No

141 (47.0)

211 (54.1)

1.00

  

Yes

159 (53.0)

179 (45.9)

0.75

0.56 – 1.02

0.064

Cocaine injection3

     

No

126 (41.9)

178 (45.5)

1.00

  

Yes

175 (58.1)

213 (54.5)

0.86

0.64 – 1.17

0.336

Amphetamine injection3

     

No

271 (90.0)

337 (86.2)

1.00

  

Yes

30 (10.0)

54 (13.8)

1.45

0.90 – 2.33

0.125

Crack cocaine smoking3

     

No

107 (35.5)

134 (34.2)

1.00

  

Yes

194 (64.5)

257 (65.7)

1.06

0.77 – 1.45

0.727

MMT3

     

No

202 (67.1)

210 (53.7)

1.00

  

Yes

99 (32.9)

181 (46.3)

1.76

1.29 – 2.40

<0.001

Time since ART initiation (per year)

5.1 (2.5 – 8.9)

6.5 (3.1 – 11.4)

0.94

0.91 – 0.97

<0.001

Median (IQR)

     

CD4+ cells at ART initiation

     

Median (IQR)

260 (150 – 390)

220 (140 – 360)

1.00

1.00 – 1.00

0.074

  1. 1. Odds Ratio; 2. 95% Confidence Interval; 3. Refers to 180 day period prior to the baseline interview.